Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 159 X posts from 158 X users, with an upper bound of 626,800 followers.

RT @Parsifaler: WORKING: Why are we seeing so much cancer? Systemic immune dysregulation correlates with cancer progression. https://t.co…

RT @Parsifaler: WORKING: Why are we seeing so much cancer? Systemic immune dysregulation correlates with cancer progression. https://t.co…

RT @Parsifaler: WORKING: Why are we seeing so much cancer? Systemic immune dysregulation correlates with cancer progression. https://t.co…

RT @Parsifaler: WORKING: Why are we seeing so much cancer? Systemic immune dysregulation correlates with cancer progression. https://t.co…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 155 additional X posts.